tert-Butyl ((1R,3R)-3-hydroxycyclopentyl)carbamate

Catalog No. :
ACSAKC037
CAS No. :
1290191-64-8
Molecular Formula :
C10H19NO3
Molecular Weight :
201.27

IUPAC Name:tert-butyl ((1R,3R)-3-hydroxycyclopentyl)carbamate

tert-Butyl ((1R,3R)-3-hydroxycyclopentyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$56.00Login to see priceIn stockInquiry
250mg95%$89.00Login to see priceIn stockIn stock
1g95%$252.00Login to see priceIn stockIn stock
5g95%$825.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((1R,3R)-3-hydroxycyclopentyl)carbamate
IUPAC Nametert-butyl ((1R,3R)-3-hydroxycyclopentyl)carbamate
MDL No.MFCD19442807
Molecular FormulaC10H19NO3
Molecular Weight201.27
SMILESO=C(OC(C)(C)C)N[C@H]1C[C@H](O)CC1
InChI KeySBUKINULYZANSP-HTQZYQBOSA-N
Synonym1290191-64-8 | tert-Butyl ((1R,3R)-3-hydroxycyclopentyl)carbamate | tert-butyl N-[(1R,3R)-3-hydroxycyclopentyl]carbamate | 207729-04-2 | TERT-BUTYL (1R,3R)-3-HYDROXYCYCLOPENTYLCARBAMATE | tert-butyl (trans-3-hydroxycyclopentyl)carbamate | Carbamic acid, N-[(1R,3R)-3-
CAS No.1290191-64-8
PubChem CID66877697

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACSAKC037 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSAKC037 route product structure diagram
    ACSAKC0371290191-64-8 In Stock
Inquiry

2. ACSAKC037 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRMTX702 route compound structure diagram
    ACRMTX7021523541-74-3 In Stock
  4. Then
  5. ACSAKC037 route product structure diagram
    ACSAKC0371290191-64-8 In Stock
Inquiry

Comments (0)